200mg.jpg)
atazanavir
Atazanavir, sold under the brand name Reyataz among others, is an antiretroviral medication used to treat HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for post-exposure prophylaxis after a needlestick injury or other potential exposure. It is taken by mouth.
Article
7 sectionsContents
- Medical uses
- Pregnancy
- Contraindications
- Adverse effects
- Mechanism of action
- Synthesis
- References
{{Drugbox | Verifiedfields = changed | verifiedrevid = 458476502 | image = Atazanavir structure.svg | image_class = skin-invert-image | width = 180 | alt = | image2 = Atazanavir ball-and-stick.png | image_class2 = bg-transparent | width2 = 220 | alt2 =
| pronounce = | tradename = Reyataz, Evotaz, others | Drugs.com = | MedlinePlus = a603019 | DailyMedID = Atazanavir | pregnancy_AU = B2 | pregnancy_AU_comment = | routes_of_administration = By mouth | ATC_prefix = J05 | ATC_suffix = AE08 | ATC_supplemental =
Gallery (4)
Connections
Categories
2-Pyridyl compoundsCYP3A4 inhibitorsDrugboxes which contain changes to verified fieldsDrugs developed by Bristol Myers SquibbDrugs with non-standard legal statusECHA InfoCard ID from WikidataHIV protease inhibitorsMethyl estersMultiple chemicals in an infobox that need indexingMultiple chemicals in Infobox drugTert-butyl compoundsWorld Health Organization essential medicines